Goldman Sachs Group »

Orchard Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Orchard Therapeutics shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Orchard Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Orchard Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Orchard Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.3M 138k 16.45
2023-06-30 $148k 28k 5.21
2023-03-31 $152k 28k 5.37